GEDI Act

I 116TH CONGRESS 1ST SESSION H. R. 3109 To provide grants to better understand and reduce gestational diabetes, and for other purposes. IN THE HOUSE OF REPRESENTATIVES JUNE 5, 2019 Mr. ENGEL (for himself and Mr. BURGESS) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To provide grants to better understand and reduce gestational diabetes, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the ‘‘Gestational Diabetes 4 Act of 2019’’ or the ‘‘GEDI Act’’. 5 SEC. 2. GESTATIONAL DIABETES. 6 Part B of title III of the Public Health Service Act 7 (42 U.S.C. 243 et seq.) is amended by inserting after sec- 8 tion 317H the following: 9 VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS 2 •HR 3109 IH ‘‘SEC. 317H–1. GESTATIONAL DIABETES. 1 ‘‘(a) UNDERSTANDING AND MONITORING GESTA- 2 TIONAL DIABETES.— 3 ‘‘(1) IN GENERAL.—The Secretary, acting 4 through the Director of the Centers for Disease 5 Control and Prevention, in consultation with the Di- 6 abetes Mellitus Interagency Coordinating Committee 7 established under section 429 and representatives of 8 appropriate national health organizations, shall de- 9 velop a multisite gestational diabetes research 10 project within the diabetes program of the Centers 11 for Disease Control and Prevention to expand and 12 enhance surveillance data and public health research 13 on gestational diabetes. 14 ‘‘(2) AREAS TO BE ADDRESSED.—The research 15 project developed under paragraph (1) shall ad- 16 dress— 17 ‘‘(A) procedures to establish accurate and 18 efficient systems for the collection of gestational 19 diabetes data within each State and common- 20 wealth, territory, or possession of the United 21 States; 22 ‘‘(B) the progress of collaborative activities 23 with the National Vital Statistics System, the 24 National Center for Health Statistics, and 25 State health departments with respect to the 26 VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS 3 •HR 3109 IH standard birth certificate, in order to improve 1 surveillance of gestational diabetes; 2 ‘‘(C) postpartum methods of tracking 3 women with gestational diabetes after delivery 4 as well as targeted interventions proven to 5 lower the incidence of type 2 diabetes in that 6 population; 7 ‘‘(D) variations in the distribution of diag- 8 nosed and undiagnosed gestational diabetes, 9 and of impaired fasting glucose tolerance and 10 impaired fasting glucose, within and among 11 groups of women; and 12 ‘‘(E) factors and culturally sensitive inter- 13 ventions that influence risks and reduce the in- 14 cidence of gestational diabetes and related com- 15 plications during childbirth, including cultural, 16 behavioral, racial, ethnic, geographic, demo- 17 graphic, socioeconomic, and genetic factors. 18 ‘‘(3) REPORT.—Not later than 2 years after the 19 date of the enactment of this section, and annually 20 thereafter, the Secretary shall generate a report on 21 the findings and recommendations of the research 22 project including prevalence of gestational diabetes 23 in the multisite area and disseminate the report to 24 the appropriate Federal and non-Federal agencies. 25 VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS 4 •HR 3109 IH ‘‘(b) EXPANSION OF GESTATIONAL DIABETES RE- 1 SEARCH.— 2 ‘‘(1) IN GENERAL.—The Secretary shall expand 3 and intensify public health research regarding gesta- 4 tional diabetes. Such research may include— 5 ‘‘(A) developing and testing novel ap- 6 proaches for improving postpartum diabetes 7 testing or screening and for preventing type 2 8 diabetes in women with a history of gestational 9 diabetes; and 10 ‘‘(B) conducting public health research to 11 further understanding of the epidemiologic, 12 socioenvironmental, behavioral, translation, and 13 biomedical factors and health systems that in- 14 fluence the risk of gestational diabetes and the 15 development of type 2 diabetes in women with 16 a history of gestational diabetes. 17 ‘‘(2) AUTHORIZATION OF APPROPRIATIONS.— 18 There is authorized to be appropriated to carry out 19 this subsection $5,000,000 for each of fiscal years 20 2020 through 2024. 21 ‘‘(c) DEMONSTRATION GRANTS TO LOWER THE 22 RATE OF GESTATIONAL DIABETES.— 23 ‘‘(1) IN GENERAL.—The Secretary, acting 24 through the Director of the Centers for Disease 25 VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS 5 •HR 3109 IH Control and Prevention, shall award grants, on a 1 competitive basis, to eligible entities for demonstra- 2 tion projects that implement evidence-based inter- 3 ventions to reduce the incidence of gestational diabe- 4 tes, the recurrence of gestational diabetes in subse- 5 quent pregnancies, and the development of type 2 di- 6 abetes in women with a history of gestational diabe- 7 tes. 8 ‘‘(2) PRIORITY.—In making grants under this 9 subsection, the Secretary shall give priority to 10 projects focusing on— 11 ‘‘(A) helping women who have 1 or more 12 risk factors for developing gestational diabetes; 13 ‘‘(B) working with women with a history of 14 gestational diabetes during a previous preg- 15 nancy; 16 ‘‘(C) providing postpartum care for women 17 with gestational diabetes; 18 ‘‘(D) tracking cases where women with a 19 history of gestational diabetes developed type 2 20 diabetes; 21 ‘‘(E) educating mothers with a history of 22 gestational diabetes about the increased risk of 23 their child developing diabetes; 24 VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS 6 •HR 3109 IH ‘‘(F) working to prevent gestational diabe- 1 tes and prevent or delay the development of 2 type 2 diabetes in women with a history of ges- 3 tational diabetes; and 4 ‘‘(G) achieving outcomes designed to assess 5 the efficacy and cost-effectiveness of interven- 6 tions that can inform decisions on long-term 7 sustainability, including third-party reimburse- 8 ment. 9 ‘‘(3) APPLICATION.—An eligible entity desiring 10 to receive a grant under this subsection shall submit 11 to the Secretary— 12 ‘‘(A) an application at such time, in such 13 manner, and containing such information as the 14 Secretary may require; and 15 ‘‘(B) a plan to— 16 ‘‘(i) lower the rate of gestational dia- 17 betes during pregnancy; or 18 ‘‘(ii) develop methods of tracking 19 women with a history of gestational diabe- 20 tes and develop effective interventions to 21 lower the incidence of the recurrence of 22 gestational diabetes in subsequent preg- 23 nancies and the development of type 2 dia- 24 betes. 25 VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS 7 •HR 3109 IH ‘‘(4) USES OF FUNDS.—An eligible entity re- 1 ceiving a grant under this subsection shall use the 2 grant funds to carry out demonstration projects de- 3 scribed in paragraph (1), including— 4 ‘‘(A) expanding community-based health 5 promotion education, activities, and incentives 6 focused on the prevention of gestational diabe- 7 tes and development of type 2 diabetes in 8 women with a history of gestational diabetes; 9 ‘‘(B) aiding State- and tribal-based diabe- 10 tes prevention and control programs to collect, 11 analyze, disseminate, and report surveillance 12 data on women with, and at risk for, gesta- 13 tional diabetes, the recurrence of gestational di- 14 abetes in subsequent pregnancies, and, for 15 women with a history of gestational diabetes, 16 the development of type 2 diabetes; and 17 ‘‘(C) training and encouraging health care 18 providers— 19 ‘‘(i) to promote risk assessment, high- 20 quality care, and self-management for ges- 21 tational diabetes and the recurrence of ges- 22 tational diabetes in subsequent preg- 23 nancies; and 24 VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS 8 •HR 3109 IH ‘‘(ii) to prevent the development of 1 type 2 diabetes in women with a history of 2 gestational diabetes, and its complications 3 in the practice settings of the health care 4 providers. 5 ‘‘(5) REPORT.—Not later than 4 years after the 6 date of the enactment of this section, the Secretary 7 shall prepare and submit to the Congress a report 8 concerning the results of the demonstration projects 9 conducted through the grants awarded under this 10 subsection. 11 ‘‘(6) DEFINITION OF ELIGIBLE ENTITY.—In 12 this subsection, the term ‘eligible entity’ means a 13 nonprofit organization (such as a nonprofit academic 14 center or community health center) or a State, trib- 15 al, or local health agency. 16 ‘‘(7) AUTHORIZATION OF APPROPRIATIONS.— 17 There is authorized to be appropriated to carry out 18 this subsection $5,000,000 for each of fiscal years 19 2020 through 2024. 20 ‘‘(d) POSTPARTUM FOLLOW-UP REGARDING GESTA- 21 TIONAL DIABETES.—The Secretary, acting through the 22 Director of the Centers for Disease Control and Preven- 23 tion, shall work with the State- and tribal-based diabetes 24 prevention and control programs assisted by the Centers 25 VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS 9 •HR 3109 IH to encourage postpartum follow-up after gestational diabe- 1 tes, as medically appropriate, for the purpose of reducing 2 the incidence of gestational diabetes, the recurrence of 3 gestational diabetes in subsequent pregnancies, the devel- 4 opment of type 2 diabetes in women with a history of ges- 5 tational diabetes, and related complications.’’. 6 Æ VerDate Sep 11 2014 00:47 Jun 14, 2019 Jkt 089200 PO 00000 Frm 00009 Fmt 6652 Sfmt 6301 E:\BILLS\H3109.IH H3109 pamtmann on DSKBFK8HB2PROD with BILLS